IMPROVEMENT CRITERIA IN DRUG TRIALS WITH NEUROTIC PATIENTS .2.

被引：81
作者：
KELLNER, R
机构：
来源：
PSYCHOLOGICAL MEDICINE | 1972年 / 2卷 / 01期
关键词：
D O I：
10.1017/S0033291700045645
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：73 / &
相关论文
共 186 条
[1]  
ABRUZZI W A, 1964, Clin Med (Northfield), V71, P1231
[2]  
ARMIGER B, 1968, THESIS ST JOHNS U
[3]   A CONTROLLED TRIAL OF IMIPRAMINE IN TREATMENT OF DEPRESSIVE STATES [J].
BALL, JRB ;
KILOH, LG .
BRITISH MEDICAL JOURNAL, 1959, 2 (NOV21) :1052-1055
[4]  
BARKER JC, 1965, BRIT J PSYCHIAT, V111, P1095, DOI 10.1192/bjp.111.480.1095
[5]   EVALUATION OF TRANYLCYPROMINE (PAR-NATE) IN TREATMENT OF DEPRESSION [J].
BARTHOLOMEW, AA .
MEDICAL JOURNAL OF AUSTRALIA, 1962, 1 (18) :655-+
[6]   COMPARATIVE TRIAL OF 4 MONO-AMINE OXIDASE-INHIBITORS ON CHRONIC DEPRESSIVES [J].
BATES, TJ ;
DOUGLAS, ADM .
JOURNAL OF MENTAL SCIENCE, 1961, 107 (448) :538-&
[7]  
BATTERMAN ROBERT C., 1963, JOUR NEW DRUGS, V3, P297
[8]   TARGET COMPLAINTS AS CRITERIA OF IMPROVEMENT [J].
BATTLE, CC ;
IMBER, SD ;
HOEHNSAR.R ;
STONE, AR ;
NASH, ER ;
FRANK, JD .
AMERICAN JOURNAL OF PSYCHOTHERAPY, 1966, 20 (01) :184-&
[9]  
BRICK H, 1965, INT J NEUROPSYCH, V1, P325
[10]  
BRICK H, 1962, DIS NERV SYST, V23, P572
12345678910